Equine Facilitated CBT Group Therapy for Youth Anxiety

NCT03838835 | Terminated

• 1 other identifier: 18-01424
• Study Type: interventional
• Target: 59
• Locations: 1 country
• Sites: 1

Brief Summary

The purpose of this study is to evaluate a 10-week equine facilitated cognitive behavioral therapy (CBT) group program for youth between ages of 6 to 17 with symptoms of anxiety. The program will be delivered at GallopNYC, a stable that provides equine-facilitated group therapy to youth with a range of mental health problems.

Conditions

Anxiety

Outcome Measures

Primary Outcomes (1)

• Anxiety, as measured by the SCARED

  41 item questionnaire scored on a 3-point Likert Scale ranging from "not true" to "very true." Items are summed, with higher scores indicating more anxiety symptoms (a cutoff of 25 indicates an anxiety disorder).

  Baseline to 10 Weeks

Study Arms (3)

Equine-facilitated group therapy

EXPERIMENTAL

Behavioral: TAU is equine-facilitated group therapy

Augmented equine-facilitated CBT group program

EXPERIMENTAL

Behavioral: Augmented equine-facilitated CBT group program

Wait List Control (WLC)

OTHER

Other: WLC

Interventions

Augmented equine-facilitated CBT group program BEHAVIORAL

Consists of CBT strategies including 1) providing psychoeducation about anxiety, 2) teaching coping strategies when anxious,and 3) identifying and addressing dysfunctional thoughts that maintain anxiety.

Augmented equine-facilitated CBT group program

TAU is equine-facilitated group therapy BEHAVIORAL

TAU is equine-facilitated group therapy at GallopNYC, which consists of horseback riding and integrates strategies to support the development of cognitive, physical, emotional, and social skills.

Equine-facilitated group therapy

WLC OTHER

WLC consists of youth who are not yet receiving any services at Gallop NYC.

Wait List Control (WLC)

Eligibility Criteria

• Age: 6 Years - 17 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Child (0-17)

You may qualify if:

• A child aged 6-17 seeking services for anxiety at Gallop NYC, who (based on the screener administered by GallopNYC) evidence symptoms of anxiety (as measured by a score of 2 or more on the GAD 2 item questionnaire) and a minimum functioning score of 51 (as measured by the child global assessment scale)
• Caregivers will also serve as study respondents. To do so, they must meet the following criteria:
• Primary caregiver/ legal guardian of a child who meets eligibility criteria
• Aged 18 years or older
• English speaking
• Providers will serve as study therapists. To do so, they must meet the following criteria:
• PATH-certified provider employed at Gallop NYC

You may not qualify if:

• Inability to provide informed consent
• Child does not meet criteria for anxiety symptoms (as measured by a score of 2 or more on the GAD 2 item questionnaire) and/or does not meet minimum level of functioning (does not meet a minimum functioning score of 51 as measured by the child global assessment scale)

Sponsors & Collaborators

• NYU Langone Health: lead

Study Sites (1)

NYU Langone Health

New York, New York, 10016, United States

Location

MeSH Terms

Conditions

Anxiety Disorders

Condition Hierarchy (Ancestors)

Mental Disorders

Study Officials

• Kimberly Hoagwood, MD

  New York Langone Medical Center

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: NONE
• Purpose: TREATMENT
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: February 11, 2019
• First Posted: February 12, 2019
• Study Start: November 15, 2018
• Primary Completion: May 26, 2020
• Study Completion: May 26, 2020
• Last Updated: September 30, 2020

Record last verified: 2020-09

Locations

US (1)